News
ViroPharma says FDA wants new study of Cinryze as treatment for acute angioedema attacks Yahoo/AP
View ArticleNews
ViroPharma Announces Publication of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Phase 3 Trial Result PR-USA.net
View ArticleViroPharma Drug Nears EU Approval
ViroPharma Drug Nears EU Approval Investor's Business Daily
View ArticleViroPharma hopes deal will bring subcutaneous form of Cinryze
ViroPharma hopes deal will bring subcutaneous form of Cinryze Bizjournals.com
View ArticleAre Supply Troubles a Biotech Buying Opportunity?
Are Supply Troubles a Biotech Buying Opportunity? Motley Fool
View ArticleDyax And ViroPharma: An Overview Of HAE Space
Dyax And ViroPharma: An Overview Of HAE Space Seeking Alpha
View ArticleViroPharma, Halozyme Rise After FDA Issue Cleared Up
ViroPharma, Halozyme Rise After FDA Issue Cleared Up Investors.com
View ArticleViroPharma up, FDA lifts ban
ViroPharma up, FDA lifts ban Yahoo/Investor's Business Daily
View ArticleSpec Stock: Cramer Profiles an Orphan Drug Maker (video)
Spec Stock: Cramer Profiles an Orphan Drug Maker (video) CNBC
View ArticleAn Interesting Bio Play in the Blood Disorder Niche
An Interesting Bio Play in the Blood Disorder Niche Motley Fool
View Article
More Pages to Explore .....
